Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tozadenant
tozadenant
Acorda writes off $363M drug, axing PhIII Parkinson’s drug in the wake of 5 patient deaths
Endpoints
Mon, 11/20/17 - 09:31 am
Acorda Therapeutics
Parkinson's Disease
tozadenant
clinical trials
Acorda faces new trouble with trial halt, safety problems
BioPharma Dive
Wed, 11/15/17 - 08:47 pm
Acorda Therapeutics
clinical trials
tozadenant
Parkinson's Disease
Acorda bags PhIII Parkinson's drug in $363M Biotie buyout
Fierce Biotech
Tue, 01/19/16 - 08:20 am
Acorda Therapeutics
Parkinson's Disease
BioTie Therapies
M&A
tozadenant